Article: 10 clinical trials to watch in the first half of 2023 https://www.biopharmadive.com/news/biotech-10-clinical-trials-watch-2023-first-half/639107/ The story on Nimbus/Takeda/4$Billion, is extraordinary, imo. ( i believe Nimbus is private) Although not in the same league as the companies in the above article, i'm adding: BDTX - Black Diamond Therapeutics https://clinicaltrials.gov/ct2/show/NCT05256290 IMTX - Immatics https://clinicaltrials.gov/ct2/show/NCT03247309 as companies with clinical trials to watch in the first half of 2023, rounding that list up to an even dozen. Any others to add to the list?